| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |